Noradrenergic antidepressants increase cortical dopamine: Potential use in augmentation strategies

Neuropharmacology

Volumn 63, Issue 4, 2012, Pages 675-684

  Masana, Mercè ^a,b   Castañé, Anna ^a   Santana, Noemí ^a   Bortolozzi, Analía ^a   Artigas, Francesc ^a  

^a INST D INVESTIGACIONS B   (Spain)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Antidepressant drugs; c fos; Catecholamines; Dopamine; Noradrenaline; Prefrontal cortex

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; DOPAMINE; MIRTAZAPINE; NORADRENALIN; REBOXETINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG POTENTIATION; FORCED SWIMMING TEST; GENE EXPRESSION; HIPPOCAMPUS; IMMOBILIZATION; LOW DRUG DOSE; MALE; NONHUMAN; NORADRENERGIC SYSTEM; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; DOPAMINE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EXTRACELLULAR FLUID; GENE EXPRESSION REGULATION; MALE; MIANSERIN; MORPHOLINES; ORGAN SPECIFICITY; PREFRONTAL CORTEX; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 84863613342     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.05.020     Document Type: Article

References (85)

1. P. Andlin-Sobocki, B. Jonsson, H.U. Wittchen, and J. Olesen Cost of disorders of the brain in Europe Eur. J. Neurol. 12 Suppl. 1 2005 1 27
2. F. Artigas, V. Perez, and E. Alvarez Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors Arch.Gen. Psychiatry 51 1994 248 251 (Pubitemid 24081512)
3. F. Artigas, L. Romero, C. de Montigny, and P. Blier Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists Trends Neurosci. 19 1996 378 383 (Pubitemid 26270513)
4. J. Ballesteros, and L.F. Callado Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials J. Affect. Disord. 79 2004 137 147 (Pubitemid 38340537)
5. C.H. Beck Acute treatment with antidepressant drugs selectively increases the expression of c-fos in the rat brain J. Psychiatry Neurosci. 20 1995 25 32
6. N. Bel, and F. Artigas Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei Synapse 15 1993 243 245 (Pubitemid 23339517)
7. C.W. Berridge, T.L. Stratford, S.L. Foote, and A.E. Kelley Distribution of dopamine beta-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens Synapse 27 1997 230 241 (Pubitemid 27430672)
8. P. Blier, and C. de Montigny Current advances and trends in the treatment of depression Trends Pharmacol. Sci. 15 1994 220 226 (Pubitemid 24210726)
9. P. Blier, H.E. Ward, P. Tremblay, L. Laberge, C. Hebert, and R. Bergeron Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study Am. J. Psychiatry 167 2010 281 288
10. A. Bortolozzi, and F. Artigas Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain. Role of alpha-adrenoceptors Neuropsychopharmacology 28 2003 421 434
11. E. Carboni, G.L. Tanda, R. Frau, and G. Di Chiara Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals J. Neurochem. 55 1990 1067 1070
12. S. Carney, and J. Geddes Electroconvulsive therapy BMJ 326 2003 1343 1344 (Pubitemid 36751026)
13. L.L. Carpenter, S. Yasmin, and L.H. Price A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine Biol. Psychiatry 51 2002 183 188 (Pubitemid 34127908)
14. V. Castagne, R.D. Porsolt, and P. Moser Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse Eur. J. Pharmacol. 616 2009 128 133
15. A. Ceci, A. Baschirotto, and F. Borsini Effect of fluoxetine on the spontaneous electrical activity of fronto-cortical neurons Eur. J. Pharmacol. 250 3 1993 461 464 (Pubitemid 24010982)
16. Y. Chandramohan, S.K. Droste, J.S. Arthur, and J.M. Reul The forced swimming-induced behavioural immobility response involves histone H3 phospho-acetylation and c-Fos induction in dentate gyrus granule neurons via activation of the N-methyl-D-aspartate/extracellular signal-regulated kinase/mitogen- and stress-activated kinase signalling pathway Eur. J. Neurosci. 27 2008 2701 2713 (Pubitemid 351781672)
17. Z. Chen, and P. Skolnick Triple uptake inhibitors: therapeutic potential in depression and beyond Expert. Opin. Investig. Drugs 16 2007 1365 1377 (Pubitemid 47491407)
18. T.J. Connor, P. Kelliher, A. Harkin, J.P. Kelly, and B.E. Leonard Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat Eur. J. Pharmacol. 379 1999 125 133
19. J.F. Cryan, A. Markou, and I. Lucki Assessing antidepressant activity in rodents: recent developments and future needs Trends Pharmacol. Sci. 23 2002 238 245 (Pubitemid 34465544)
20. J.F. Cryan, M.E. Page, and I. Lucki Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test Eur. J. Pharmacol. 436 2002 197 205 (Pubitemid 34164699)
21. J.F. Cryan, R.J. Valentino, and I. Lucki Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test Neurosci. Biobehav. Rev. 29 2005 547 569 (Pubitemid 40755456)
22. P.S. D'Aquila, M. Collu, G.L. Gessa, and G. Serra The role of dopamine in the mechanism of action of antidepressant drugs Eur. J. Pharmacol. 405 2000 365 373
23. J.M. Delfs, Y. Zhu, J.P. Druhan, and G.S. Aston-Jones Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat Brain Res. 806 1998 127 140 (Pubitemid 29010488)
24. M.J. Detke, M. Rickels, and I. Lucki Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants Psychopharmacology (Berl.) 121 1995 66 72
25. P. Devoto, and G. Flore On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons? Curr. Neuropharmacol. 4 2006 115 125
26. P. Devoto, G. Flore, L. Pani, and G.L. Gessa Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex Mol. Psychiatry 6 2001 657 664 (Pubitemid 33020584)
27. P. Devoto, G. Flore, P. Saba, M. Fa, and G.L. Gessa Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex J. Neurochem. 92 2005 368 374 (Pubitemid 40194027)
28. R.S. Duman Role of neurotrophic factors in the etiology and treatment of mood disorders Neuromolecular Med. 5 2004 11 25 (Pubitemid 38391953)
29. E.F. Espejo, and F.J. Minano Prefrontocortical dopamine depletion induces antidepressant-like effects in rats and alters the profile of desipramine during Porsolt's test Neuroscience 88 1999 609 615 (Pubitemid 28480019)
30. S.L. Foote, F.E. Bloom, and G. Aston-Jones Nucleus locus ceruleus: new evidence of anatomical and physiological specificity Physiol. Rev. 63 1983 844 914 (Pubitemid 13048718)
31. P.S. Goldman-Rakic, S.A. Castner, T.H. Svensson, L.J. Siever, and G.V. Williams Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction Psychopharmacolgy (Berl.) 174 2004 3 16 (Pubitemid 38925085)
32. P.S. Goldman-Rakic The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia Biol. Psychiatry 46 1999 650 661 (Pubitemid 29401861)
33. P. Haddad Do antidepressants have any potential to cause addiction? J. Psychopharmacol. 13 1999 300 307 (Pubitemid 29435798)
34. R.W. Invernizzi, and S. Garattini Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies Prog. Neuropsychopharmacol. Biol. Psychiatry 28 2004 819 827 (Pubitemid 39195273)
35. S.R. Jones, R.R. Gainetdinov, M. Jaber, B. Giros, R.M. Wightman, and M.G. Caron Profound neuronal plasticity in response to inactivation of the dopamine transporter Proc. Natl. Acad. Sci. U. S. A 95 1998 4029 4034 (Pubitemid 28173248)
36. L. Kargieman, N. Santana, G. Mengod, P. Celada, and F. Artigas Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine Proc. Natl. Acad. Sci. U. S. A 104 2007 14843 14848 (Pubitemid 350003230)
37. H. Kawahara, Y. Kawahara, and B.H. Westerink The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis Eur. J. Pharmacol. 418 2001 177 186 (Pubitemid 32441577)
38. R.C. Kessler, W.T. Chiu, O. Demler, K.R. Merikangas, and E.E. Walters Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Arch. Gen. Psychiatry 62 2005 617 627 (Pubitemid 40973437)
39. M.J. Kuhar, M.C. Ritz, and J.W. Boja The dopamine hypothesis of the reinforcing properties of cocaine Trends Neurosci. 14 1991 299 302
40. F. Lavergne, and T.M. Jay A new strategy for antidepressant prescription Front. Neurosci. 4 2010 192
41. L. Llado-Pelfort, N. Santana, V. Ghisi, F. Artigas, and P. Celada 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons Cereb Cortex 2012 10.1093/cercor/bhr220
42. F. Lopez-Munoz, G. Rubio, C. Alamo, P. Garcia-Garcia, and A. Pardo Reboxetine addition in patients with mirtazapine-resistant depression: a case series Clin. Neuropharmacol. 29 2006 192 196 (Pubitemid 44510455)
43. S.D. Mague, A.M. Pliakas, M.S. Todtenkopf, H.C. Tomasiewicz, Y. Zhang, W.C. Stevens Jr., R.M. Jones, P.S. Portoghese, and W.A. Carlezon Jr. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats J. Pharmacol. Exp. Ther. 305 2003 323 330 (Pubitemid 36373867)
44. M. Masana, A. Bortolozzi, and F. Artigas Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia Int. J. Neuropsychopharmacol. 14 2011 53 68
45. Y. Mateo, J. Pineda, and J.J. Meana Somatodendritic alpha2-adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine J. Neurochem. 71 1998 790 798 (Pubitemid 28480428)
46. Y. Mateo, B. Fernandez-Pastor, and J.J. Meana Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study Br. J. Pharmacol. 133 2001 1362 1370 (Pubitemid 32783498)
47. H.S. Mayberg, A.M. Lozano, V. Voon, H.E. McNeely, D. Seminowicz, C. Hamani, J.M. Schwalb, and S.H. Kennedy Deep brain stimulation for treatment-resistant depression Neuron 45 2005 651 660 (Pubitemid 40320700)
48. M.S. Mazei, C.P. Pluto, B. Kirkbride, and E.A. Pehek Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat Brain Res. 936 2002 58 67 (Pubitemid 34461933)
49. M.J. Millan Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs Neurotherapeutics 6 2009 53 77
50. S. Miyata, T. Hamamura, Y. Lee, M. Miki, T. Habara, T. Oka, S. Endo, H. Taoka, and S. Kuroda Contrasting Fos expression induced by acute reboxetine and fluoxetine in the rat forebrain: neuroanatomical substrates for the antidepressant effect Psychopharmacology (Berl.) 177 2005 289 295 (Pubitemid 40137289)
51. E.J. Nestler, M. Barrot, R.J. DiLeone, A.J. Eisch, S.J. Gold, and L.M. Monteggia Neurobiology of depression Neuron 34 2002 13 25 (Pubitemid 34270695)
52. M. Nibuya, S. Morinobu, and R.S. Duman Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments J. Neurosci. 15 1995 7539 7547
53. J.E. Ortega, B. Fernandez-Pastor, L.F. Callado, and J.J. Meana In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by alpha(2)-adrenoceptor antagonism Eur. Neuropsychopharmacol. 20 2010 813 822
54. M.E. Page, M.J. Detke, A. Dalvi, L.G. Kirby, and I. Lucki Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test Psychopharmacology (Berl.) 147 1999 162 167 (Pubitemid 30010563)
55. M.E. Page, K. Brown, and I. Lucki Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action Psychopharmacology (Berl.) 165 2003 194 201 (Pubitemid 36056997)
56. G.I. Papakostas, J.J. Worthington III, D.V. Iosifescu, G. Kinrys, A.M. Burns, L.B. Fisher, C.H. Homberger, D. Mischoulon, and M. Fava The combination of duloxetine and bupropion for treatment-resistant major depressive disorder Depress. Anxiety 23 2006 178 181 (Pubitemid 43727149)
57. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1998 Academic Sydney
58. V. Perez, I. Gilaberte, D. Faries, E. Alvarez, and F. Artigas Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment Lancet 349 1997 1594 1597 (Pubitemid 27229140)
59. V. Perez, J. Soler, D. Puigdemont, E. Alvarez, and F. Artigas A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius Arch. Gen. Psychiatry 56 1999 375 379 (Pubitemid 29165184)
60. A.M. Pliakas, R.R. Carlson, R.L. Neve, C. Konradi, E.J. Nestler, and W.A. Carlezon Jr. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens J. Neurosci. 21 2001 7397 7403 (Pubitemid 32846987)
61. M.J. Portella, J. de Diego-Adelino, J. Ballesteros, D. Puigdemont, S. Oller, B. Santos, E. Alvarez, F. Artigas, and V. Perez Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression J. Clin. Psychiatry 72 2011 962 969
62. L. Pozzi, R. Invernizzi, L. Cervo, F. Vallebuona, and R. Samanin Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats J. Neurochem. 63 1994 195 200 (Pubitemid 24184918)
63. D. Puigdemont, R. Perez-Egea, M.J. Portella, J. Molet, J. de Diego-Adelino, A. Gironell, J. Radua, B. Gomez-Anson, R. Rodriguez, M. Serra, C. de Quintana, F. Artigas, E. Alvarez, and V. Perez Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression Int. J. Neuropsychopharmacol. 2011 1 13
64. J.P. Reneric, and I. Lucki Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test Psychopharmacology (Berl.) 136 1998 190 197 (Pubitemid 28137959)
65. J.P. Reneric, M. Bouvard, and L. Stinus Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test Neuropsychopharmacology 24 2001 379 390 (Pubitemid 32157554)
66. J.P. Reneric, M. Bouvard, and L. Stinus In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed Eur. Neuropsychopharmacol. 12 2002 159 171 (Pubitemid 34168482)
67. A.A. Russo-Neustadt, H. Alejandre, C. Garcia, A.S. Ivy, and M.J. Chen Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise Neuropsychopharmacology 29 12 2004 2189 2199 (Pubitemid 39578909)
68. G. Sacchetti, M. Bernini, A. Bianchetti, S. Parini, R.W. Invernizzi, and R. Samanin Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain Br. J. Pharmacol. 128 1999 1332 1338
69. S.M. Sagar, F.R. Sharp, and T. Curran Expression of c-fos protein in brain: metabolic mapping at the cellular level Science 240 4857 1988 1328 1331
70. P. Salchner, and N. Singewald Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment Neuropharmacology 43 8 2002 1238 1248 (Pubitemid 36084434)
71. N. Santana, E. Troyano-Rodriguez, G. Mengod, P. Celada, and F. Artigas Activation of thalamocortical networks by the N-methyl-D-aspartate receptor antagonist phencyclidine: reversal by clozapine Biol. Psychiatry 69 10 2011 918 927
72. M.C. Scorza, A. Castane, A. Bortolozzi, and F. Artigas Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801 Clz and MK-801 in KO1A mice Neuropharmacology 59 2010 112 120
73. P. Seguela, K.C. Watkins, M. Geffard, and L. Descarries Noradrenaline axon terminals in adult rat neocortex: an immunocytochemical analysis in serial thin sections Neuroscience 35 1990 249 264 (Pubitemid 20176738)
74. D.A. Slattery, J.A. Morrow, A.L. Hudson, D.R. Hill, D.J. Nutt, and B. Henry Comparison of alterations in c-fos and Egr-1 (zif268) expression throughout the rat brain following acute administration of different classes of antidepressant compounds Neuropsychopharmacology 30 2005 1278 1287 (Pubitemid 40848082)
75. K. Smith Trillion-dollar brain drain Nature 478 7367 2011 15
76. I. Sora, F.S. Hall, A.M. Andrews, M. Itokawa, X.F. Li, H.B. Wei, C. Wichems, K.P. Lesch, D.L. Murphy, and G.R. Uhl Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference Proc. Natl. Acad. Sci. U. S. A 98 2001 5300 5305 (Pubitemid 32397123)
77. S.S. Stone, C.M. Teixeira, L.M. Devito, K. Zaslavsky, S.A. Josselyn, A.M. Lozano, and P.W. Frankland Stimulation of entorhinal cortex promotes adult neurogenesis and facilitates spatial memory J. Neurosci. 31 2011 13469 13484
78. P. Svenningsson, E.T. Tzavara, H. Qi, R. Carruthers, J.M. Witkin, G.G. Nomikos, and P. Greengard Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation J. Neurosci. 27 2007 4201 4209 (Pubitemid 46597167)
79. G. Torres, J.M. Horowitz, N. Laflamme, and S. Rivest Fluoxetine induces the transcription of genes encoding c-fos, corticotropin-releasing factor and its type 1 receptor in rat brain Neuroscience 87 1998 463 477 (Pubitemid 28370903)
80. M.H. Trivedi, M. Fava, S.R. Wisniewski, M.E. Thase, F. Quitkin, D. Warden, L. Ritz, A.A. Nierenberg, B.D. Lebowitz, M.M. Biggs, J.F. Luther, K. Shores-Wilson, and A.J. Rush Medication augmentation after the failure of SSRIs for depression N. Engl. J. Med. 354 2006 1243 1252
81. T. van Groen, P. Miettinen, and I. Kadish The entorhinal cortex of the mouse: organization of the projection to the hippocampal formation Hippocampus 13 1 2003 133 149 (Pubitemid 36312926)
82. R. Whale, T. Terao, P. Cowen, N. Freemantle, and J. Geddes Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review J. Psychopharmacol. 24 2010 513 520
83. W.L. Woolverton, and K.M. Johnson Neurobiology of cocaine abuse Trends Pharmacol. Sci. 13 1992 193 200
84. M. Yamauchi, T. Imanishi, and T. Koyama A combination of mirtazapine and milnacipran augments the extracellular levels of monoamines in the rat brain Neuropharmacology 62 7 2012 2278 2287
85. S.U. Yanpallewar, K. Fernandes, S.V. Marathe, K.C. Vadodaria, D. Jhaveri, K. Rommelfanger, U. Ladiwala, S. Jha, V. Muthig, L. Hein, P. Bartlett, D. Weinshenker, and V.A. Vaidya Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment J. Neurosci. 30 2010 1096 1109